The key finding of this study is that both SFN and BITC effectively inhibit the growth of SKM-1 acute myeloid leukemia (AML) cells and their P-glycoprotein (P-gp)-overexpressing drug-resistant variant, SKM/VCR. This evidence concerns the gene PGP and acute myeloid leukemia.